Cannabis, the Gut Microbiota, and Infectious Diseases
🔍 CED Perspective Lens: Cannabis, the Gut Microbiota, and Infectious Diseases
Dr. Benjamin Caplan, MD
The gut microbiota, the community of microorganisms living in the digestive tract, shapes digestion, immunity, and susceptibility to disease, and emerging research suggests that cannabinoids can influence its composition and function. This guide walks through the diagram that links cannabis, gut bacteria, and health outcomes, and says where the evidence stands.
Unpacking the Interplay: Cannabis, Gut Microbiota, and Health Outcomes
The gut microbiota, a diverse community of microorganisms residing in the digestive tract, plays a critical role in maintaining health and immunity and in modulating susceptibility to various diseases. Emerging research suggests that cannabinoids, the compounds found in cannabis, can influence the composition and function of the gut microbiota, with possible effects on health and on susceptibility to or progression of illness.
Role of Gut Microbiota in Health, Immunity, and Disease
The gut microbiota contributes to digestion, metabolism, and the synthesis of essential nutrients, while also significantly influencing immune system regulation (Thursby 2017). Dysbiosis, an imbalance in the gut microbiota, has been implicated in conditions such as inflammatory bowel disease (IBD), obesity, and even neurodegenerative disorders (Quigley 2017).
Potential Influence of Cannabinoids on Gut Microbiota
Cannabinoids like cannabidiol (CBD) and tetrahydrocannabinol (THC) interact with the endocannabinoid system, which is closely involved in gut physiology. Some studies suggest that cannabinoids can modulate the gut microbiota, either promoting or suppressing the growth of specific bacterial strains. Most of that work is in animals, and the human picture is still forming.
Impact on Susceptibility to or Progression of Illness
Changes in gut microbiota influenced by cannabinoids could affect susceptibility to diseases like IBD, metabolic disorders, and certain infections. Cannabinoids have been shown to reduce intestinal inflammation in animal models of IBD, and the endocannabinoid system is a recognized therapeutic target in these diseases (Alhouayek 2012). A systematic review and meta-analysis of cannabinoids in colitis found consistent benefit in animal models but concluded that the human clinical evidence was still limited (Couch 2018).
What This Does and Does Not Show
The diagram is a schematic of a plausible chain of effects: cannabinoids act on the endocannabinoid system, the endocannabinoid system shapes gut physiology, and gut physiology shapes the microbiota and immune regulation. It does not report which bacterial strains change in people who use cannabis, in which direction, or at what dose. The related CED guides on cannabis compounds for GI issues and cannabis and gut health cover the clinical side.
References
- Thursby E, Juge N. Introduction to the human gut microbiota. Biochemical Journal. 2017;474(11):1823-1836.
- Quigley EMM. Microbiota-Brain-Gut Axis and Neurodegenerative Diseases. Current Neurology and Neuroscience Reports. 2017;17(12):94.
- Couch DG, Maudslay H, Doleman B, Lund JN, O’Sullivan SE. The Use of Cannabinoids in Colitis: A Systematic Review and Meta-Analysis. Inflammatory Bowel Diseases. 2018;24(4):680-697.
- Alhouayek M, Muccioli GG. The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity. Trends in Molecular Medicine. 2012;18(10):615-625.
This page is a reconstruction of the original CaplanCannabis.com guide. The book that grew out of that series, The Doctor-Approved Cannabis Handbook, is available here.
Frequently Asked Questions
Can cannabis change the gut microbiota?
Some studies suggest that cannabinoids can modulate the gut microbiota, either promoting or suppressing the growth of specific bacterial strains. Most of that work is in animals, and the human picture is still forming.
What does the gut microbiota do?
It contributes to digestion, metabolism, and the synthesis of essential nutrients, and it significantly influences immune system regulation.
What is dysbiosis?
An imbalance in the gut microbiota. It has been implicated in conditions such as inflammatory bowel disease, obesity, and even neurodegenerative disorders.
Do cannabinoids help inflammatory bowel disease?
Cannabinoids reduce intestinal inflammation in animal models of IBD, and the endocannabinoid system is a recognized therapeutic target. A systematic review and meta-analysis found consistent benefit in animal models but limited human clinical evidence.
Does the diagram show which bacteria change with cannabis use?
No. It shows a plausible chain of effects from cannabinoids to the endocannabinoid system to gut physiology and immune regulation. It does not report which strains change, in which direction, or at what dose.